Allogene Therapeutics, Inc. (ALLO) Insider Ownership

Historic Insider Ownership Trends

Allogene Therapeutics's three largest insider shareholders as of March 23, 2026 are David D Chang (President And Ceo, 5.19Mn shares), Arie Belldegrun (Director, 2.24Mn shares), Arie Belldegrun (Director, 1.72Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
David D Chang President And Ceo 5,150,599 0 18 Mar, 2026
Arie Belldegrun 2,236,816 0 28 Jan, 2025
Arie Belldegrun 0 1,724,137 20 May, 2024
Geoffrey M. Parker Chief Financial Officer 1,252,795 0 04 Feb, 2026
Eric Thomas Schmidt Chief Financial Officer 862,439 0 24 Mar, 2023
David D Chang President And Ceo 0 856,044 02 Apr, 2021
Alison Moore Chief Technical Officer 672,731 0 24 Mar, 2023
Zachary Roberts Evp Of Rd 581,166 0 04 Feb, 2026
Earl Martin Douglas Svp, General Counsel 564,948 0 04 Feb, 2026
Veer Bhavnagri General Counsel 556,049 0 16 Mar, 2023
Rafael Amado Evp Of Rd 541,946 0 11 Oct, 2022
Joshua A Kazam 350,763 0 22 Dec, 2025
Franz B Humer 307,507 0 09 Dec, 2024
Owen N. Witte 292,832 0 15 Jun, 2023
Timothy L. Moore Chief Technical Officer 250,713 0 05 Feb, 2025
Benjamin Machinas Beneski Svp, Chief Technical Officer 198,205 0 18 Mar, 2026
Vicki L Sato 162,575 0 07 Jun, 2024
Lillian Smith Vp, Corporate Counsel 140,390 0 05 Apr, 2023
Annie Yoshiyama Svp, Finance 130,322 0 04 Feb, 2026
Deborah M. Messemer 107,431 0 12 Jun, 2025
Yinlin Jack Chen Svp, Finance 88,881 0 14 Aug, 2023
Stephen Mayo 25,328 0 09 Aug, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
16 Mar, 2026 David D Chang Common Stock D 47,763 $2.47 5,150,599 D S
16 Mar, 2026 Benjamin Machinas Beneski Common Stock D 4,835 $2.47 198,205 D S
02 Mar, 2026 Benjamin Machinas Beneski Common Stock D 7,132 $2.60 203,040 D S
02 Feb, 2026 Geoffrey M. Parker Common Stock D 24,001 $1.76 1,252,795 D S
02 Feb, 2026 David D Chang Common Stock D 95,269 $1.80 5,185,862 D S
02 Feb, 2026 Zachary Roberts Common Stock D 35,700 $1.77 581,166 D S
02 Feb, 2026 Benjamin Machinas Beneski Common Stock D 7,549 $1.73 210,172 D S
02 Feb, 2026 Annie Yoshiyama Common Stock D 4,167 $1.72 130,322 D S
02 Feb, 2026 Earl Martin Douglas Common Stock D 22,900 $1.76 564,948 D S
02 Feb, 2026 Earl Martin Douglas Stock Option (Right to buy) A 539,072 $0.00 539,072 D A
02 Feb, 2026 Zachary Roberts Stock Option (Right to buy) A 718,763 $0.00 718,763 D A
02 Feb, 2026 Annie Yoshiyama Stock Option (Right to buy) A 179,691 $0.00 179,691 D A
02 Feb, 2026 Geoffrey M. Parker Stock Option (Right to buy) A 539,072 $0.00 539,072 D A
02 Feb, 2026 Benjamin Machinas Beneski Stock Option (Right to buy) A 373,757 $0.00 373,757 D A
02 Feb, 2026 Geoffrey M. Parker Restricted Stock Unit A 152,480 $0.00 152,480 D A
02 Feb, 2026 Annie Yoshiyama Restricted Stock Unit A 50,827 $0.00 50,827 D A
02 Feb, 2026 Earl Martin Douglas Restricted Stock Unit A 152,480 $0.00 152,480 D A
02 Feb, 2026 Zachary Roberts Restricted Stock Unit A 203,307 $0.00 203,307 D A
02 Feb, 2026 Benjamin Machinas Beneski Restricted Stock Unit A 105,720 $0.00 105,720 D A
02 Feb, 2026 David D Chang Stock Option (Right to buy) A 1,387,931 $0.00 1,387,931 D A